Genome editing using Staphylococcus aureus Cas9 in a canine model of glycogen storage disease Ia-Reference-Cited by-同舟云学术

Genome editing using Staphylococcus aureus Cas9 in a canine model of glycogen storage disease Ia

Published:2023-06 Issue: Volume:29 Page:108-119
ISSN:2329-0501
Container-title:Molecular Therapy - Methods & Clinical Development
language:en
Short-container-title:Molecular Therapy - Methods & Clinical Development

Author:

Arnson Benjamin,Kang Hye Ri,Brooks Elizabeth D.,Gheorghiu Dorothy,Ilich Ekaterina,Courtney David,Everitt Jeffrey I.,Cullen Bryan R.,Koeberl Dwight D.^ORCID

Publisher

Elsevier BV

Subject

Genetics,Molecular Biology,Molecular Medicine

Reference32 articles.

1. Emerging therapies for glycogen storage disease type I;Koeberl;Trends Endocrinol. Metabol.,2009

2. Diagnosis and management of glycogen storage disease type I: a practice guideline of the American College of Medical Genetics and Genomics;Kishnani;Genet. Med.,2014

3. Early, sustained efficacy of adeno-associated virus vector-mediated gene therapy in glycogen storage disease type Ia;Koeberl;Gene Ther.,2006

4. Prevention of hepatocellular adenoma and correction of metabolic abnormalities in murine glycogen storage disease type Ia by gene therapy;Lee;Hepatology,2012

5. Hepatorenal correction in murine glycogen storage disease type I with a double-stranded adeno-associated virus vector;Luo;Mol. Ther.,2011

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. mRNA therapies: Pioneering a new era in rare genetic disease treatment;Journal of Controlled Release;2024-05

2. IA´ Tools for the development of investigative skills;LatIA;2023-11-30

3. CRISPR/Cas9‐based double‐strand oligonucleotide insertion strategy corrects metabolic abnormalities in murine glycogen storage disease type‐Ia;Journal of Inherited Metabolic Disease;2023-08-18

4. Gene therapy for glycogen storage diseases;Journal of Inherited Metabolic Disease;2023-07-27

5. From Puppies to adults: In vivo editing of hepatocytes in a canine model of glycogen storage disease type Ia;Molecular Therapy - Methods & Clinical Development;2023-06